Home › Funds › LOWE BROCKENBROUGH & CO INC › ABBV

LOWE BROCKENBROUGH & CO INC position in ABBV

ABBVIE INC · Health Care

LOWE BROCKENBROUGH & CO INC reported holding 62,552 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$16.4M, representing 0.70% of its reported portfolio and ranking #39 among its reported holdings. LOWE BROCKENBROUGH & CO INC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)62.55K sh
Reported value held$16.36M
Portfolio Weight0.70%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LOWE BROCKENBROUGH & CO INC's ABBV position evolved

LOWE BROCKENBROUGH & CO INC first disclosed a stake in ABBV in Q3 2023 at 31,929 shares (US$4.8M). The position peaked in Q3 2026 at 62,552 shares, worth US$16.4M. Across 13 filings, LOWE BROCKENBROUGH & CO INC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 62,552 shares valued at US$16.4M — an increase of 33,371 shares quarter over quarter.. Notable position changes include a 114% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 31.93K $4.76M New
Q4 2023 33.54K $5.20M Add
Q1 2024 28.24K $5.14M Reduce
Q2 2024 26.98K $4.63M Reduce
Q3 2024 31.27K $6.18M Add
Q4 2024 30.86K $5.48M Reduce
Q1 2025 30.53K $6.40M Reduce
Q2 2025 31.84K $5.91M Add
Q3 2025 31.73K $7.35M Hold
Q4 2025 31.36K $7.17M Reduce
Q1 2026 30.64K $6.66M Reduce
Q2 2026 29.18K $7.34M Reduce
Q3 2026 62.55K $16.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has LOWE BROCKENBROUGH & CO INC held ABBV?

LOWE BROCKENBROUGH & CO INC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LOWE BROCKENBROUGH & CO INC's current position in ABBV?

As of Q3 2026, LOWE BROCKENBROUGH & CO INC holds 62.55K shares of ABBV (ABBVIE INC), valued at $16.36M, representing 0.70% of its reported portfolio and ranking #39.

Has LOWE BROCKENBROUGH & CO INC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), LOWE BROCKENBROUGH & CO INC increased its position in ABBV. The position peaked in Q3 2026 at 62.55K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.